© 2026 swii.ch health
Exploring the ideas, innovations, and individuals shaping the future of rare disease.
EU Joint Clinical Assessment (JCA) is still early in its implementation. Much of the formal framework is[…]
As we move into 2026, EU Joint Clinical Assessments (JCAs) are shifting from policy concept to operational[…]